---
figid: PMC9266536__ijms-23-07426-g002
figtitle: 'Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Streptococcus suis 93A
organisms_ner:
- Mus musculus
pmcid: PMC9266536
filename: ijms-23-07426-g002.jpg
figlink: /pmc/articles/PMC9266536/figure/ijms-23-07426-f002/
number: F2
caption: Schematic diagram of fenretinide activity in neurological diseases. Pointed
  arrows represent pathway activation, and blunt arrows represent pathway inhibition.
  Fenretinide activates PKCδ in the mitochondrial signalosome with consequent activation
  of PDK2, PDHC, TCA and increased ROS production. Low doses of fenretinide induce
  a moderate increase of intracellular ROS with activation of JNK autophagy pathway.
  Fenretinide decreases oxidative stress by improving the expression of the transcription
  factor Nrf2 that promotes the transcription of the antioxidant responsive element
  (ARE). Fenretinide downregulates the production of proinflammatory cytokines in
  macrophages by decreasing the AA/DHA ratio and enhancing the expression of PPARγ.
  Fenretinide binds RBP4 in place of retinol thereby decreasing circulating levels
  of both retinol and RBP4.
papertitle: 'Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule.'
reftext: Rosa Luisa Potenza, et al. Int J Mol Sci. 2022 Jul;23(13):7426.
year: '2022'
doi: 10.3390/ijms23137426
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: fenretinide | anticancer drugs | nanomicellar formulations | repositioning
  | neuroinflammation | oxidative stress | neuroprotection | hormesis
automl_pathway: 0.9541901
figid_alias: PMC9266536__F2
figtype: Figure
redirect_from: /figures/PMC9266536__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9266536__ijms-23-07426-g002.html
  '@type': Dataset
  description: Schematic diagram of fenretinide activity in neurological diseases.
    Pointed arrows represent pathway activation, and blunt arrows represent pathway
    inhibition. Fenretinide activates PKCδ in the mitochondrial signalosome with consequent
    activation of PDK2, PDHC, TCA and increased ROS production. Low doses of fenretinide
    induce a moderate increase of intracellular ROS with activation of JNK autophagy
    pathway. Fenretinide decreases oxidative stress by improving the expression of
    the transcription factor Nrf2 that promotes the transcription of the antioxidant
    responsive element (ARE). Fenretinide downregulates the production of proinflammatory
    cytokines in macrophages by decreasing the AA/DHA ratio and enhancing the expression
    of PPARγ. Fenretinide binds RBP4 in place of retinol thereby decreasing circulating
    levels of both retinol and RBP4.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pdk2
  - Mapk8
  - Gnat2
  - Nfe2l2
  - Alpha-re
  - Rbp4
  - H2-Aa
---
